Nanjing, China – May 30, 2024 – MICRO-TECH celebrated the grand opening of its new manufacturing campus with a milestone ceremony attended by over 300 distinguished guests, including leading clinical and engineering experts, physicians, and global partners from across China and more than a dozen countries. The event marked a major step forward in the company’s commitment to innovation, production excellence, and global impact.
Located in the Nanjing Biotech and Pharmaceutical Valley, the new facility spans approximately 120,000 square meters. It includes state-of-the-art production space, warehousing, shared public areas, multifunctional offices, and preparation rooms for future capacity. The completion of this new campus marks a solid stride in scaling up MICRO-TECH’s manufacturing capabilities, enhancing product quality, and boosting global competitiveness.
A Milestone Witnessed by Leaders and Partners
The ceremony was graced by esteemed guests including Academician Teng Gaojun of the Chinese Academy of Sciences and President of Zhongda Hospital, Southeast University; Mr. Long Xiaohui, Chairman of MICRO-TECH; Mr. Wang Wei, Deputy Director of the Administrative Committee of Jiangbei New Area; along with officials from provincial and municipal government departments. The CEO of MICRO-TECH Mr. Leng Derong hosted the event.
Academician Teng, a long-standing clinical partner of MICRO-TECH, shared four key words summarizing the company’s success: technological innovation, clinical-engineering collaboration, internationalization, and government support. He emphasized that these elements have collectively driven MICRO-TECH’s growth and expressed his hope that the company will seize this moment to reach new heights in integrated med-tech innovation.
Mr. Wang Wei remarked that the new facility reflects MICRO-TECH’s commitment to efficiency and growth, as well as the strong partnership between the company and the Jiangbei New Area. He encouraged MICRO-TECH to continue focusing on frontier innovation in medical technology and reaffirmed the district’s full support for the company’s future development.
A New Beginning for a Growing Company
In his address, Chairman Long described the transformation from MICRO-TECH’s humble beginnings to its current scale as “a seedling that has finally grown tall.” He highlighted the dramatic improvements in workspace design, scale, and smart functionality, as well as the upgrades to laboratories and exhibition hall. “This new building is not only a major milestone since our IPO five years ago,” he said, “but also a powerful new starting point.”
Speeches were also delivered by international partners and physicians, who shared stories of collaboration and mutual growth with MICRO-TECH across global markets.
MICRO-TECH’s Growing Global Presence
As the first company in Nanjing and among the earliest in China to be listed on the STAR Market (Shanghai Stock Exchange Science and Technology Innovation Board), MICRO-TECH has long focused on the R&D, manufacturing, and commercialization of minimally invasive medical devices. With flagship products such as disposable biopsy forceps, stents, and Hemostatic Clip, the company has successfully driven domestic substitution in key clinical areas—demonstrating the power of Chinese innovation.
Today, MICRO-TECH serves over 6,000 hospitals across China, covering more than 55% of the country’s top-tier hospitals. Its business also spans more than 90 countries and regions, supported by a robust global sales and service network that anchors its international reach.
The opening of the new campus represents not just a physical upgrade, but a renewed mission. “A building is not a symbol of sustainable strength,” Chairman Long concluded. “Our true potential lies in the people inside—those who pursue excellence, embrace innovation, and rise to meet the challenges ahead.”
